annual operating expenses:
$791.68M+$33.50M(+4.42%)Summary
- As of today (August 4, 2025), ACAD annual total operating expenses is $791.68 million, with the most recent change of +$33.50 million (+4.42%) on December 31, 2024.
- During the last 3 years, ACAD annual operating expenses has risen by +$156.23 million (+24.59%).
- ACAD annual operating expenses is now at all-time high.
Performance
ACAD Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$204.63M-$26.18M(-11.34%)Summary
- As of today (August 4, 2025), ACAD quarterly total operating expenses is $204.63 million, with the most recent change of -$26.18 million (-11.34%) on March 31, 2025.
- Over the past year, ACAD quarterly operating expenses has increased by +$36.97 million (+22.05%).
- ACAD quarterly operating expenses is now -19.70% below its all-time high of $254.85 million, reached on September 30, 2023.
Performance
ACAD quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ACAD Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.4% | +22.1% |
| 3 y3 years | +24.6% | -9.3% |
| 5 y5 years | +39.9% | +17.2% |
ACAD Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +24.6% | -19.7% | +32.3% |
| 5 y | 5-year | at high | +39.9% | -19.7% | +45.9% |
| alltime | all time | at high | +4981.0% | -19.7% | +4854.0% |
ACAD Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $204.63M(-11.3%) |
| Dec 2024 | $791.68M(+4.4%) | $230.81M(+15.5%) |
| Sep 2024 | - | $199.90M(+3.4%) |
| Jun 2024 | - | $193.30M(+15.3%) |
| Mar 2024 | - | $167.67M(-5.9%) |
| Dec 2023 | $758.18M(+3.8%) | $178.21M(-30.1%) |
| Sep 2023 | - | $254.85M(+64.7%) |
| Jun 2023 | - | $154.74M(-9.2%) |
| Mar 2023 | - | $170.38M(-5.4%) |
| Dec 2022 | $730.66M(+15.0%) | $180.14M(+13.0%) |
| Sep 2022 | - | $159.44M(-3.7%) |
| Jun 2022 | - | $165.55M(-26.6%) |
| Mar 2022 | - | $225.53M(+30.5%) |
| Dec 2021 | $635.44M(-10.2%) | $172.85M(+23.3%) |
| Sep 2021 | - | $140.23M(-8.8%) |
| Jun 2021 | - | $153.72M(-8.8%) |
| Mar 2021 | - | $168.63M(-7.8%) |
| Dec 2020 | $707.79M(+25.0%) | $182.87M(-9.3%) |
| Sep 2020 | - | $201.68M(+35.7%) |
| Jun 2020 | - | $148.64M(-14.9%) |
| Mar 2020 | - | $174.61M(+16.9%) |
| Dec 2019 | $566.02M(+25.0%) | $149.39M(+10.4%) |
| Sep 2019 | - | $135.32M(+0.0%) |
| Jun 2019 | - | $135.30M(-7.3%) |
| Mar 2019 | - | $146.01M(+19.2%) |
| Dec 2018 | $452.92M(+12.0%) | $122.45M(+7.2%) |
| Sep 2018 | - | $114.20M(-1.6%) |
| Jun 2018 | - | $116.06M(+15.8%) |
| Mar 2018 | - | $100.20M(-8.8%) |
| Dec 2017 | $404.25M(+41.5%) | $109.87M(+12.1%) |
| Sep 2017 | - | $98.01M(+2.8%) |
| Jun 2017 | - | $95.31M(-5.7%) |
| Mar 2017 | - | $101.07M(+15.0%) |
| Dec 2016 | $285.74M(+76.2%) | $87.88M(+15.1%) |
| Sep 2016 | - | $76.35M(+7.2%) |
| Jun 2016 | - | $71.25M(+41.7%) |
| Mar 2016 | - | $50.27M(+16.7%) |
| Dec 2015 | $162.17M(+73.7%) | $43.08M(+10.4%) |
| Sep 2015 | - | $39.04M(-1.2%) |
| Jun 2015 | - | $39.50M(-2.6%) |
| Mar 2015 | - | $40.56M(+41.8%) |
| Dec 2014 | $93.35M(+136.7%) | $28.60M(+14.4%) |
| Sep 2014 | - | $25.01M(+15.0%) |
| Jun 2014 | - | $21.75M(+20.9%) |
| Mar 2014 | - | $17.99M(+47.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $39.44M(+52.9%) | $12.20M(+10.4%) |
| Sep 2013 | - | $11.05M(+15.0%) |
| Jun 2013 | - | $9.61M(+46.0%) |
| Mar 2013 | - | $6.58M(-8.6%) |
| Dec 2012 | $25.79M(+3.5%) | $7.20M(+22.3%) |
| Sep 2012 | - | $5.88M(-2.4%) |
| Jun 2012 | - | $6.03M(-9.8%) |
| Mar 2012 | - | $6.68M(+13.2%) |
| Dec 2011 | $24.92M(-7.8%) | $5.90M(+4.0%) |
| Sep 2011 | - | $5.68M(-19.4%) |
| Jun 2011 | - | $7.04M(+11.9%) |
| Mar 2011 | - | $6.30M(+0.3%) |
| Dec 2010 | $27.04M(-47.9%) | $6.28M(-4.1%) |
| Sep 2010 | - | $6.54M(-0.8%) |
| Jun 2010 | - | $6.59M(-13.6%) |
| Mar 2010 | - | $7.63M(-27.2%) |
| Dec 2009 | $51.87M(-24.4%) | $10.47M(-6.5%) |
| Sep 2009 | - | $11.21M(-23.4%) |
| Jun 2009 | - | $14.64M(-5.8%) |
| Mar 2009 | - | $15.54M(+6.9%) |
| Dec 2008 | $68.57M(-2.3%) | $14.54M(-11.2%) |
| Sep 2008 | - | $16.37M(-14.8%) |
| Jun 2008 | - | $19.22M(-0.1%) |
| Mar 2008 | - | $19.25M(-5.1%) |
| Dec 2007 | $70.21M(+22.8%) | $20.29M(+2.2%) |
| Sep 2007 | - | $19.85M(+35.4%) |
| Jun 2007 | - | $14.66M(-4.9%) |
| Mar 2007 | - | $15.41M(+0.6%) |
| Dec 2006 | $57.19M(+22.3%) | $15.32M(+5.8%) |
| Sep 2006 | - | $14.48M(-1.8%) |
| Jun 2006 | - | $14.74M(+16.7%) |
| Mar 2006 | - | $12.64M(-3.8%) |
| Dec 2005 | $46.76M(+52.3%) | $13.14M(-20.3%) |
| Sep 2005 | - | $16.49M(+83.0%) |
| Jun 2005 | - | $9.01M(+10.9%) |
| Mar 2005 | - | $8.13M(-4.8%) |
| Dec 2004 | $30.70M(+45.4%) | $8.54M(+8.0%) |
| Sep 2004 | - | $7.90M(+14.5%) |
| Jun 2004 | - | $6.90M(-6.2%) |
| Mar 2004 | - | $7.36M(+70.1%) |
| Dec 2003 | $21.12M(+11.7%) | - |
| Jun 2003 | - | $4.32M(+4.7%) |
| Mar 2003 | - | $4.13M |
| Dec 2002 | $18.90M(-0.5%) | - |
| Dec 2001 | $18.99M(+21.9%) | - |
| Dec 2000 | $15.58M | - |
FAQ
- What is ACADIA Pharmaceuticals Inc. annual total operating expenses?
- What is the all time high annual operating expenses for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. annual operating expenses year-on-year change?
- What is ACADIA Pharmaceuticals Inc. quarterly total operating expenses?
- What is the all time high quarterly operating expenses for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. quarterly operating expenses year-on-year change?
What is ACADIA Pharmaceuticals Inc. annual total operating expenses?
The current annual operating expenses of ACAD is $791.68M
What is the all time high annual operating expenses for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high annual total operating expenses is $791.68M
What is ACADIA Pharmaceuticals Inc. annual operating expenses year-on-year change?
Over the past year, ACAD annual total operating expenses has changed by +$33.50M (+4.42%)
What is ACADIA Pharmaceuticals Inc. quarterly total operating expenses?
The current quarterly operating expenses of ACAD is $204.63M
What is the all time high quarterly operating expenses for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high quarterly total operating expenses is $254.85M
What is ACADIA Pharmaceuticals Inc. quarterly operating expenses year-on-year change?
Over the past year, ACAD quarterly total operating expenses has changed by +$36.97M (+22.05%)